Thoma Bravo and Madison Dearborn Partners Sell Syntellis Performance Solutions to Roper Technologies

Madison Dearborn Partners (MDP) and Thoma Bravo today announced that they have completed the sale of Syntellis Performance Solutions (Syntellis), a leading provider of enterprise performance management (EPM) software, data, and intelligence solutions, to Roper Technologies, Inc. (Roper) in an all-cash transaction for an enterprise value of $1.4 billion. Syntellis will be combined with Roper’s Strata Decision Technology business. Syntellis became an independent company with the investment support of Thoma Bravo and MDP when it was separated from Kaufman Hall in August 2020. Over the past three years, MDP and Thoma Bravo have worked closely with Syntellis and its management team to enhance and innovate the company’s integrated EPM solutions to better serve Syntellis’s growing global client base. During this period, Syntellis made meaningful investments in product and platform enhancements, including to its Axiom365 SaaS offering, and enhanced its planning and performance product offering by acquiring Stratasan, an industry leader in advanced healthcare market intelligence and data analytics. “Thoma Bravo and MDP’s support and collaboration have propelled our growth, helped advance our product roadmap, and enabled us to better serve our valued clients,” said Flint Brenton, Chief Executive Officer at Syntellis. “Today’s announcement is a testament to the great work from the entire Syntellis team and marks an exciting new chapter for the company. As part of Roper,...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT A.J. Rohde Flint Brenton Health IT Acquisitions Healthcare M&A Jason Shideler Kirkland & Ellis LLP Madison Dearborn Partners MDP Roper Roper Technologies Strata Decision Technology Syntellis Synt Source Type: blogs